China Resources Pharmaceutical (03320): The net profit attributable to Donga Ejiao shareholders in the first half of the year was 860 million yuan, an increase of 5.66% year-on-year

According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that Donga Ejiao, a subsidiary of the Group, achieved total operating income of 3.155 billion yuan for the six months ended June 30, 2026, an increase of 3.39%; net profit attributable to shareholders of listed companies was 860 million yuan, an increase of 5.66% over the previous year; and basic profit per share was 1.34 yuan.